Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Significance of plasma fibrinogen and malondialdehyde in the post-inflammatory period in patients with cystic fibrosis

Ondrej Hloch, Libor Fila, Jan Havlin, Jiri Charvat, Sabina Palova

. 2022 ; 123 (3) : 149-152.

Jazyk angličtina Země Slovensko

Typ dokumentu práce podpořená grantem, hodnotící studie, klinická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc22026099

OBJECTIVES: Evaluation of selected inflammatory parameters and serum malondialdehyde (MDA) significance in the post-inflammatory period in adult patients with cystic fibrosis. BACKGROUND: Laboratory biomarkers can be integrated into clinical practice as part of monitoring the effectiveness of treatment. METHODS: After recovery from an acute exacerbation of lung infection, selected inflammatory parameters (fibrinogen, IL-1, IL-6, SAA, hs-CRP) and serum MDA were examined in 30 adult patients with cystic fibrosis. Their correlation with FEV1, frequency and duration of subsequent hospitalizations and 6-year prognosis in terms of mortality or need for lung transplantation was evaluated. RESULTS: FEV1 negatively correlated with fibrinogen, but positively with MDA. No significant correlation with hs-CRP, IL-1, IL-6 and SAA was recorded. Plasma fibrinogen predicted the frequency and duration of subsequent hospitalizations. The 6-year prognosis was negatively associated with plasma fibrinogen whereas its association with MDA was positive. However, the prognosis of patients in the multivariate analysis was significantly associated only with FEV1. CONCLUSION: Plasma fibrinogen examined in the post-inflammatory period is a marker of lung damage in patients with cystic fibrosis and can be used to predict the prognosis. The positive correlation of serum MDA with FEV1 in the post-inflammatory period may be important to the interpretation of treatment interventions (Tab. 3, Fig. 2, Ref. 17).

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc22026099
003      
CZ-PrNML
005      
20230110133813.0
007      
ta
008      
221102s2022 xo d fs 000 0|eng||
009      
AR
024    0_
$a 10.4149/BLL_2022_025 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xo
100    1_
$a Hloch, Ondřej $7 xx0175745 $u Department of Internal Medicine and Department of Pneumology, 2nd Faculty Medicine of Charles University and Faculty Hospital Prague Motol, Prague, Czech Republic
245    10
$a Significance of plasma fibrinogen and malondialdehyde in the post-inflammatory period in patients with cystic fibrosis / $c Ondrej Hloch, Libor Fila, Jan Havlin, Jiri Charvat, Sabina Palova
504    __
$a Literatura
520    9_
$a OBJECTIVES: Evaluation of selected inflammatory parameters and serum malondialdehyde (MDA) significance in the post-inflammatory period in adult patients with cystic fibrosis. BACKGROUND: Laboratory biomarkers can be integrated into clinical practice as part of monitoring the effectiveness of treatment. METHODS: After recovery from an acute exacerbation of lung infection, selected inflammatory parameters (fibrinogen, IL-1, IL-6, SAA, hs-CRP) and serum MDA were examined in 30 adult patients with cystic fibrosis. Their correlation with FEV1, frequency and duration of subsequent hospitalizations and 6-year prognosis in terms of mortality or need for lung transplantation was evaluated. RESULTS: FEV1 negatively correlated with fibrinogen, but positively with MDA. No significant correlation with hs-CRP, IL-1, IL-6 and SAA was recorded. Plasma fibrinogen predicted the frequency and duration of subsequent hospitalizations. The 6-year prognosis was negatively associated with plasma fibrinogen whereas its association with MDA was positive. However, the prognosis of patients in the multivariate analysis was significantly associated only with FEV1. CONCLUSION: Plasma fibrinogen examined in the post-inflammatory period is a marker of lung damage in patients with cystic fibrosis and can be used to predict the prognosis. The positive correlation of serum MDA with FEV1 in the post-inflammatory period may be important to the interpretation of treatment interventions (Tab. 3, Fig. 2, Ref. 17).
650    _7
$a dospělí $7 D000328 $2 czmesh
650    _7
$a ženské pohlaví $7 D005260 $2 czmesh
650    _7
$a lidé $7 D006801 $2 czmesh
650    _7
$a mužské pohlaví $7 D008297 $2 czmesh
650    _7
$a fibrinogen $x analýza $7 D005340 $2 czmesh
650    _7
$a malondialdehyd $x analýza $7 D008315 $2 czmesh
650    17
$a cystická fibróza $x krev $7 D003550 $2 czmesh
650    17
$a biologické markery $x krev $7 D015415 $2 czmesh
650    _7
$a dechový objem $7 D013990 $2 czmesh
650    _7
$a prognóza $7 D011379 $2 czmesh
650    _7
$a korelace dat $7 D000078331 $2 czmesh
650    _7
$a klinické zhoršení $7 D000075902 $2 czmesh
655    _7
$a práce podpořená grantem $7 D013485 $2 czmesh
655    _7
$a hodnotící studie $7 D023362 $2 czmesh
655    _7
$a klinická studie $7 D000068397 $2 czmesh
700    1_
$a Fila, Libor, $d 1968- $7 ola2006345307 $u Department of Internal Medicine and Department of Pneumology, 2nd Faculty Medicine of Charles University and Faculty Hospital Prague Motol, Prague, Czech Republic
700    1_
$a Havlín, Jan $7 xx0093656 $u 3rd Department of Surgery, 1st Faculty of Medicine of Charles University and Faculty Hospital Prague Motol, Czech Republic
700    1_
$a Charvát, Jiří, $d 1948- $7 pna2005261832 $u Department of Internal Medicine and Department of Pneumology, 2nd Faculty Medicine of Charles University and Faculty Hospital Prague Motol, Prague, Czech Republic
700    1_
$a Pálová, Sabina $7 xx0128164 $u Department of Internal Medicine and Department of Pneumology, 2nd Faculty Medicine of Charles University and Faculty Hospital Prague Motol, Prague, Czech Republic
773    0_
$t Bratislavské lekárske listy $x 0006-9248 $g Roč. 123, č. 3 (2022), s. 149-152 $w MED00000845
856    41
$u http://www.elis.sk/download_file.php?product_id=7576&session_id=5hob67buame1h4jbqk1qin6737 $y plný text volně přístupný
910    __
$a ABA008 $b online $c 1067 $y p $z 0
990    __
$a 20221101161338 $b ABA008
991    __
$a 20230110133810 $b ABA008
999    __
$a ok $b bmc $g 1855743 $s 1177403
BAS    __
$a 3
BMC    __
$a 2022 $b 123 $c 3 $d 149-152 $i 0006-9248 $m Bratislavské lekárske listy $x MED00000845
LZP    __
$c NLK189 $d 20221217 $a NLK 2022-22/kv

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...